Create an Account
Welcome & Mission Statement
User Technical Support
Accreditation Legend
System Requirements
10th Annual UCI Neuromuscular Colloquium
Provided with the 5th Annual UCI Pathology Colloquium!
Activity Details
Activity Name: 10th Annual UCI Neuromuscular Colloquium
Description: Provided with the 5th Annual UCI Pathology Colloquium!
Needs Assessment: Gap:
Expert Needs:
This is the 10th and 5th events in the annual series on Neuromuscular Diseases and Neuromuscular Pathology being planned. The program has been developed and tailored based on areas of new disease-related information identified by the Planning Committee with further input from the faculty panel and recent advances in the literature relating to neuromuscular diseases. As an example, recent successful trials have led to FDA's approval of new drugs for the treatment of Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy and Myasthenia Gravis.
Participant Needs:
Modifications to the Program have been made based on feedback obtained from the participants after the previous event in the series.
Observed Needs:
The recent approval of novel immune modulatory therapy in Myasthenia Gravis has opened up new possibilities in terms of time of intervention as well as treatment outcomes for disease exacerbations, crises, and even refractory disease. This has led to several new investigational therapies in the pipeline for the coming year and these therapies are likely to eventually lead to treatment paradigm changes.
Course Objectives: Objectives:
* Describe the ongoing in-human gene therapy trials in myotubular myopathy and their preliminary results
* Identify different clinical presentations and patterns of involvement in neuromuscular diseases
* Describe current diagnostic and management strategies in rare and orphan neuromuscular diseases
* Recognize the potential systemic complications in these disorders
* List current standards and guidelines for management
* Explain the difference between primary inflammatory myopathies vs. myopathies secondary to connective tissue disease
* Identify features helpful in distinguishing acquired myopathies from inherited myopathies
* Identify features on muscle pathology that help prognosticate for cancer or interstitial lung disease
Location Information
Meeting Location: Hyatt Regency Beach Resort & Spa
Meeting Location URL:
Location Address: 21500 Pacific Coast Hwy.
Location City: Huntington Beach
Location State: CA
Location Postal Code: 92648
Location Country: US
City Information URL:
Activity Information
Start Date: 6/4/2020
End Date: 6/5/2020
Credit Information
Credit Amount: 12
Credit Unit: Credits
Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format: Live Activity
Sponsor Name: UCI School of Medicine
Sponsor Address: 836 Health Sciences Road
Sponsor City: Irvine
Sponsor State: CA
Sponsor Postal Code: 92697
Sponsor Country: US
Sponsor Phone: 949.824.2394
Sponsor Email:
Contact Information
Contact Name: Michi Baylon
Contact Address: 200 S. Manchester Ave., Ste. 206
Contact City: Orange
Contact State: CA
Contact Postal Code: 92868
Contact Country: US
Contact Phone: 714.456.1691
Contact Email:

Type:     Live Activity
2 Registered Users